In this issue of GeneLetter , we continue an analysis of this important topic. The goal of this group is to enhance the public's health through better integration of progress in human genetics into health care. Dr. Muin Khoury, its director, will be a regular contributor on this and related topics to GeneLetter . Sally Lehrman writes about another public's view of genetics. Out of cultural difference and historical experience, indigenous peoples in this country and elsewhere can view genetic research with alarm.
More consumers knowing their risks makes successful insurance products harder to create.
Cantor has a potential solution that may have other benefits. Those without health care insurance die at a higher rate than those with financing. If that increased death rate impacts fertility, our current system may be a new form of eugenic public policy. If Cantor's proposal sets an adequate minimum level of health care and can support it financially, a new eugenics may be averted. And noting the deeper information basis and powerful tools of genetic medicine also should be considered as a role for the state is reviewed.